Principles of Vaccine Licensure, Approval, and Recommendations for Use
- PMID: 32063358
- DOI: 10.1016/j.mayocp.2019.11.002
Principles of Vaccine Licensure, Approval, and Recommendations for Use
Abstract
The licensure and recommendation processes for vaccines are complex. In the United States, vaccines are licensed for the civilian and military populations on the basis of review of Biologics License Applications submitted to the Food and Drug Administration (FDA) by vaccine manufacturers. For FDA-licensed vaccines, the product label includes indications, contraindications, and precautions for each vaccine. Package inserts do not include recommendations for vaccine use from the Advisory Committee on Immunization Practices (ACIP). The ACIP is chartered as a federal advisory committee to provide expert external advice and guidance to the director of the Centers for Disease Control and Prevention on the use of vaccines and related agents for control of vaccine preventable diseases in the civilian and military populations of the United States. As an external advisory committee to the Centers for Disease Control and Prevention, the ACIP has no regulatory authority but the committee does have responsibility for approving vaccines to be covered under the Vaccines for Children program. To implement ACIP vaccine recommendations in the public and private sectors, a collaboration of federal, state, and local governments as well as private organizations dealing with public health, vaccine supply, vaccine administration, vaccine finance, outcomes monitoring, public perception, and public trust and support must work together. Issues including vaccine misinformation, declining community immunity (herd protection), and need for risk communication add stress to this complex and fragile system. This study describes the functions of and interactions between FDA and ACIP.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Discrepancies Between US Food and Drug Administration Vaccine Licensure Indications and Advisory Committee on Immunization Practices Recommendations: Provider Knowledge and Attitudes.Clin Ther. 2018 Aug;40(8):1308-1319.e16. doi: 10.1016/j.clinthera.2018.07.004. Epub 2018 Aug 11. Clin Ther. 2018. PMID: 30108001
-
FDA licensure of and ACIP recommendations for vaccines.Vaccine. 2017 Sep 5;35(37):5027-5036. doi: 10.1016/j.vaccine.2017.07.023. Epub 2017 Jul 29. Vaccine. 2017. PMID: 28765004
-
Licensure, Approval, and Uptake of Vaccines in the United States.J Pediatric Infect Dis Soc. 2018 Dec 26;7(suppl_2):S46-S48. doi: 10.1093/jpids/piy122. J Pediatric Infect Dis Soc. 2018. PMID: 30590618
-
Vaccines in the pipeline: the path from development to use in the United States.Pediatr Ann. 2013 Aug;42(8):146-52. doi: 10.3928/00904481-20130723-08. Pediatr Ann. 2013. PMID: 23910027 Review.
-
Strengthening vaccination policies in Latin America: an evidence-based approach.Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25. Vaccine. 2013. PMID: 23357196 Review.
Cited by
-
COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination.Renew Sustain Energy Rev. 2021 Oct;150:111400. doi: 10.1016/j.rser.2021.111400. Epub 2021 Jul 6. Renew Sustain Energy Rev. 2021. PMID: 34248390 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials